BioCentury
ARTICLE | Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

Newly launched K2HV intends to redirect some returns from debt and equity investments to ‘underserved and underinvested’ areas

May 21, 2019 10:42 PM UTC

Newly launched venture debt and equity investor K2 HealthVentures says it will redirect some of its returns to “underserved and underinvested” areas of the life sciences and healthcare sphere as it invests the first $400 million from what it believes will be a permanent capital base.

The firm, whose founding managing director and CEO is Hercules Capital (NYSE:HTGC) veteran Parag Shah, is backed by the L1 Health division of Luxembourg-based family office Letterone Holdings S.A. K2HV’s launch is part of L1 Health’s commitment to provide up to $3 billion overall to healthcare companies...

BCIQ Company Profiles

Hercules Capital Inc.